Table 2 Patient demographics
From: The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis
|  | Overall, N = 1015 | No self-reported anxiety/depression, n = 625 | Self-reported anxiety/depression, n = 390 | P-value (atest) |
|---|---|---|---|---|
Patient age, years | ||||
 Mean (SD) | 55.2 (14.1) | 54.3 (14.6) | 56.7 (13.1) | .012 (MW) |
Gender, n (%) | ||||
 Female | 733 (72.2) | 431 (69.0) | 302 (77.4) | .004 (FE) |
Years since RA diagnosis | ||||
 Mean, years (SD) | 7.5 (7.4) | 6.7 (7.0) | 8.7 (7.9) | .001 (MW) |
 bMissing, n | 69 | 38 | 31 |  |
Current severity level, n (%) | ||||
 Mild | 682 (67.2) | 479 (76.6) | 203 (52.1) |  |
 Moderate | 294 (29.0) | 138 (22.1) | 156 (40.0) |  |
 Severe | 39 (3.8) | 8 (1.3) | 31 (7.9) | <.001 (MW) |
Current pain level (1–10) | ||||
 Mean (SD) | 3.3 (2.0) | 2.8 (1.7) | 4.1 (2.2) | <.001 (MW) |
On biologic therapy, n (%) | ||||
Receiving biologic therapy/on break but expected to restart | 469 (46.2) 20 (2.0) | 264 (42.2) 10 (1.6) | 205 (52.6) 10 (2.6) | .002 (FE) |
Discontinued biologic, n (%) | 30 (3.0) | 16 (2.6) | 14 (3.6) | 0.636 (PC) |